This is not the most recent version of the article. View current version (12 SEP 2012)

Intervention Protocol

Black cohosh (Cimicifuga spp.) for menopausal symptoms

  1. Matthew J Leach1,*,
  2. Vivienne Moore2

Editorial Group: Cochrane Menstrual Disorders and Subfertility Group

Published Online: 16 JUL 2008

Assessed as up-to-date: 11 MAY 2008

DOI: 10.1002/14651858.CD007244


How to Cite

Leach MJ, Moore V. Black cohosh (Cimicifuga spp.) for menopausal symptoms (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD007244. DOI: 10.1002/14651858.CD007244.

Author Information

  1. 1

    University of South Australia, School of Health Sciences, Adelaide, South Australia, Australia

  2. 2

    University of Adelaide, Department of Public Health, Adelaide, South Australia, Australia

*Matthew J Leach, School of Health Sciences, University of South Australia, North Terrace, Adelaide, South Australia, 5000, Australia. Matthew.leach@unisa.edu.au.

Publication History

  1. Publication Status: Edited (no change to conclusions)
  2. Published Online: 16 JUL 2008

SEARCH

This is not the most recent version of the article. View current version (12 SEP 2012)

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

The objective of this systematic review is to evaluate the clinical effectiveness of black cohosh (Cimicifuga racemosa or Actaea racemosa) in perimenopausal and postmenopausal women.

The specific review questions to be addressed are:
- How effective is black cohosh in perimenopausal and postmenopausal women at reducing the frequency or intensity of menopausal symptoms?
- How safe is black cohosh in perimenopausal and postmenopausal women when taken to alleviate the symptoms of menopause?